Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Estradiol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 6/20 | 1.00 |
| ▸ | LMNA | P02545 | 5/20 | 1.00 |
| ▸ | ESR2 | Q92731 | 5/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 2/20 | 1.00 |
| ▸ | SHBG | P04278 | 2/20 | 1.00 |
| ▸ | PGR | P06401 | 2/20 | 1.00 |
| ▸ | SERPINA6 | P08185 | 2/20 | 1.00 |
| ▸ | AR | P10275 | 2/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 2/20 | 1.00 |
| ▸ | SNCA | P37840 | 2/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Estradiol SCHEMBL961326 | 1.00 | ESR1 (1.00) | ESR1LMNAESR2HSD17B10TSHR | |
| Estradiol SCHEMBL10039358 | 1.00 | ESR1 (1.00) | ESR1LMNAESR2HSD17B10TSHR | |
| Estradiol SCHEMBL8049 | 1.00 | ESR1 (1.00) | ESR1LMNAESR2HSD17B10TSHR | |
| Estradiol SCHEMBL19235633 | 1.00 | ESR1 (1.00) | ESR1LMNAESR2HSD17B10TSHR | |
| Estradiol SCHEMBL15610005 | 1.00 | ESR1 (1.00) | ESR1LMNAESR2HSD17B10TSHR | |
| Estradiol SCHEMBL15610524 | 1.00 | ESR1 (1.00) | ESR1LMNAESR2HSD17B10TSHR | |
| Estradiol SCHEMBL24037697 | 1.00 | ESR1 (1.00) | ESR1LMNAESR2HSD17B10TSHR | |
| Estradiol SCHEMBL7037626 | 1.00 | ESR1 (1.00) | ESR1LMNAESR2HSD17B10TSHR | |
| Estradiol SCHEMBL18258335 | 1.00 | ESR1 (1.00) | ESR1LMNAESR2HSD17B10TSHR | |
| Estradiol SCHEMBL19217062 | 1.00 | ESR1 (1.00) | ESR1LMNAESR2HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10695450-B2 | Synthesis of a radioactive agent composition | LABORATOIRES CYCLOPHARMA (FR) | 2020-06-30 | — | — | US | disclosed |
| US-20180028695-A1 | SYNTHESIS OF A RADIOACTIVE AGENT COMPOSITION | GE HEALTHCARE LIMITED (GB) | 2018-02-01 | — | — | US | disclosed |
| WO-2017133517-A1 | PHOSPHAMIDE DERIVATIVE, METHOD FOR MANUFACTURING THE SAME, AND USES THEREOF | 四川海思科制药有限公司 | 2017-08-10 | — | — | WO | disclosed |
| WO-2012020417-A1 | PROCESS FOR THE PREPARATION OF ESTRADIOL AND ITS DERIVATIVES | RELIANCE LIFE SCIENCES PVT. LTD. (IN) | 2012-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10695450-B2 | Synthesis of a radioactive agent composition | MGMT, LPO, REV1 | ESR1 4097/4885LMNA 2475/4885ESR2 1916/4885 |
| US-20180028695-A1 | SYNTHESIS OF A RADIOACTIVE AGENT COMPOSITION | MGMT, LPO, REV1 | ESR1 4097/4885LMNA 2475/4885ESR2 1916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.